Items Tagged with 'AMR'

In an effort to address the “silent pandemic” of antimicrobial resistance (AMR), a recently concluded UK Animal and Plant Health Agency (APHA)–FAO project has helped partners across Africa and Asia to improve their AMR detection, analysis, and mitigation capabilities.

Controlling foodborne antimicrobial resistance requires a One Health approach centered on food hygiene. Although antimicrobial stewardship can slow the emergence and enrichment of resistant bacteria, existing environmental reservoirs mean that resistant bacteria can contaminate food regardless of antimicrobial use.

Antimicrobial resistance (AMR) is recognized as a crucial threat to global public health. Antimicrobial use in animal agriculture can contribute to the emergence and spread of increasingly drug-resistant foodborne pathogens, impacting human medicine.

A new study found high levels of multidrug resistance and biofilm formation among Enterococcus spp. isolated from retail meat, market workers, and consumers. Genetic similarities among E. faecalis and E. faecium isolates from different sources suggested potential cross-transmission at the food–human interface, although the researchers emphasized that direct transmission was not established.

The co-occurrence of biofilm formation, acid tolerance, and antimicrobial resistance genes in E. coli isolated from irrigation water, soil, and crops could complicate downstream microbial control efforts in produce production systems.

Overuse or misuse of antimicrobials and improper disposal of antimicrobials in the agri-food system may result in food and environmental contamination and contribute to the global rise of AMR.

Citing concerns about antibiotic overuse in food-producing animals contributing to the spread of antimicrobial resistance (AMR), the petition calls for FDA to withdraw approvals for the routine use of medically important drugs for disease prevention.

The review summarized current knowledge about the potential contribution of foodborne bacteria and antibiotic resistance genes to the human gut resistome, suggesting the integration of gut microbiome and AMR data into risk assessment frameworks.

Per CDC and USDA-FSIS data, in 2023, Salmonella Infantis strain REPJFX01 accounted for 97 percent of S. Infantis isolates and 21 percent of all Salmonella recovered from chicken carcasses. This rising trend is closely aligned with an increase in human salmonellosis infections linked to REPJFX01.

The proportion of extensively drug-resistant isolates rose from 0 percent during 2011–2015 to 8.5 percent in 2023.